MAYNF MAYNE PHARMA GROUP LIMITED
- 4.460000
- 0.0000000.00%
MAYNE PHARMA GROUP LIMITED News
Analysts Expect Breakeven For Mayne Pharma Group Limited (ASX:MYX) Before Long
Mayne Pharma Group Reports 1H Results
Earnings Call Summary | MAYNE PHARMA GROUP LIMITED(MAYNF.US) Q2 2024 Earnings Conference
The following is a summary of the Mayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call Transcript:Financial Performance:Mayne Pharma reported a gross profit of $105.8 million, reflecting a margin
Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the firm's stock in a transaction on Thursday, April 13th. The stock was acquired at an average cost of A
There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues
Frank Condella Is The Independent Non-Executive Chairman of Mayne Pharma Group Limited (ASX:MYX) And They Just Picked Up 56% More Shares
Mayne Pharma Group Limited (ASX:MYX) Insider Acquires A$11,289.57 in Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Frank Condella purchased 3,210 shares of the company's stock in a transaction dated Monday, March 27th. The stock was purchased at an average
Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Decreases By 87.5%
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling
Mayne Pharma Group Limited (ASX:MYX) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Prescription Generic Deal
Dr. Reddy's Laboratories Ltd (NYSE:RDY) has agreed to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited (OTC:MAYND) (OTC:MAYNF) (OTC:MYPHY). Under t
Dr. Reddy's to Acquire U.S. Generic Portfolio of Mayne Pharma
Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Expands By 2,081.6%
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totallin
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Short Interest Up 88.9% in December
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 62
Mayne Pharma Group Limited (ASX:MYX) Most Popular Amongst Individual Investors Who Own 56% of the Shares, Institutions Hold 20%
Analysts' Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH) and Mayne Pharma Group Limited (OtherMAYNF)
Canaccord Genuity Sticks to Their Buy Rating for Mayne Pharma Group Limited (MAYNF)
Mayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Sees Large Decline in Short Interest
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest tota
Analysts Are More Bearish On Mayne Pharma Group Limited (ASX:MYX) Than They Used To Be
One thing we could say about the analysts on Mayne Pharma Group Limited (ASX:MYX) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the
Analysts' Top Healthcare Picks: Mayne Pharma Group Limited (MAYNF), Mesoblast Limited (MEOBF)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mayne Pharma Group Limited (MAYNF – Research Report) and Mesoblast Limited (MEOBF – Research Report) with
Analysis
Price Target
No Data
